Based on our previous finding that EBV DNA increases the incidence and severity of arthritis in a CIA mouse model [18], we investigated the potential therapeutic effect of TLR9 inhibition on EBV DNA-exacerbated arthritis. The gene discussed is TLR9; the disease is Arthritis.